LPAA Launch One Acquisition Corp.

CIK 0002015502 8 ready 8-Ks latest June 2, 2026, 5:15 PM ET RSS · JSON

Activity: NORMAL 1 filings / 30d vs 0 baseline

Ready 8-Ks 8

Latest filing June 2, 2026, 5:15 PM ET

Top materiality 0.75

Event mix other_material ×3 · m_and_a ×2 · leadership ×1

Sentiment 0 pos · 2 neg · 6 neu

Executive change recent →

Recent 8-K filings for LPAA

Highest-materiality recent filing

Launch One Acquisition terminates business combination with Minovia Therapeutics

February 4, 2026, 6:59 PM ET other material materiality 0.75 negative item 1.02 item 9.01 ◈ Material Agreements

Mutual termination effective Jan 30, 2026; BCA originally signed June 25, 2025 and amended four times.
Each party released the others from all liabilities and damages related to the transaction documents.

Read filing →

June 2, 2026, 5:15 PM ET leadership materiality 0.35 neutral item 5.02 ◈ executive_change ×2

Launch One Acquisition Corp appoints Daniel Clifford Rogers to board, replacing Risa Stack as audit committee chair

Dr. Risa Stack resigned from the Board and as audit committee chair, effective June 2, 2026; no disagreement cited.
March 26, 2026, 7:59 PM ET debt materiality 0.55 negative item 2.03 item 8.01 item 9.01 ◈ Debt Financings

Launch One Acquisition secures up to $1M working capital note from sponsor; 51% founder shares pledged as collateral

Note allows up to $1,000,000 in loans; original issue discount of 20% yields $1,250,000 principal amount.
February 4, 2026, 6:59 PM ET other material materiality 0.75 negative item 1.02 item 9.01 ◈ Material Agreements

Launch One Acquisition terminates business combination with Minovia Therapeutics

Mutual termination effective Jan 30, 2026; BCA originally signed June 25, 2025 and amended four times.
July 1, 2025, 7:59 PM ET M&A materiality 0.75 neutral item 1.01 item 9.01

Launch One SPAC to acquire Minovia Therapeutics in $180M de-SPAC merger

Total consideration $180M in Pubco shares, plus $57.5M earnout tied to stock price ≥$11.50 or phase 3 trial start.
June 25, 2025, 7:59 PM ET M&A materiality 0.75 neutral item 7.01 item 9.01

Launch One Acquisition Corp. to combine with Minovia Therapeutics at $180M valuation, targeting Q4 2025 close

Minovia pre-money valuation of $180M; equity holders eligible for up to $57.5M earnout based on milestones.
August 29, 2024, 7:59 PM ET other materiality 0.10 neutral item 8.01 item 9.01

Launch One Acquisition announces separate trading of shares and warrants from September 3, 2024

Holders of units (LPAAU) may elect to separate into Class A shares (LPAA) and warrants (LPAAW) starting September 3, 2024.
July 19, 2024, 7:59 PM ET other material materiality 0.75 neutral item 8.01 item 9.01

Launch One Acquisition Corp. completes $230M IPO and $6M private placement

Sold 23M units at $10.00 each (including full over-allotment of 3M units) for gross proceeds of $230M.
July 15, 2024, 7:59 PM ET other material materiality 0.50 neutral item 1.01 item 2.03 item 3.02 item 5.03 item 8.01 item 9.01

Launch One Acquisition Corp. closes $230M IPO, trust funded

Closed IPO of 23,000,000 units at $10.00/unit, gross proceeds $230M; includes full over-allotment exercise.

Executive changes

Departed

Risa Stack

Director and chairperson of the audit committee

LPAA · Launch One Acquisition Corp.

Effective: 2026-06-02
Successor: Daniel Clifford Rogers
Filed: June 2, 2026, 5:15 PM ET

June 2, 2026, the board of directors (the " Board ") of Launch One Acquisition Corp. (the " Company ") appointed Daniel Clifford Rogers as a member of the Board. Mr. Rogers was appointed as a replacement for Dr. Risa Stack, who resigned from the Board and as chairperson of the audit committee of the Board (the " Audit Committee "), and as a member of the compensation committee of the Board, effective as of the same date.

Appointed

Daniel Clifford Rogers

Director and chairperson of the audit committee

LPAA · Launch One Acquisition Corp.

Effective: 2026-06-02
Filed: June 2, 2026, 5:15 PM ET

June 2, 2026, the board of directors (the " Board ") of Launch One Acquisition Corp. (the " Company ") appointed Daniel Clifford Rogers as a member of the Board. Mr. Rogers was appointed as a replacement for Dr. Risa Stack, who resigned from the Board and as chairperson of the audit committee of the Board (the " Audit Committee "), and as a member of the compensation committee of the Board, effective as of the same date.

Materiality & sentiment trend

Max materiality 0.75 · Median 0.65 · Most common event other_material

0 positive 2 negative 6 neutral

source · LPAA on sec.gov